IRBM Drug Discovery Chemistry, April 18-21, 2022
Experimental and in silico approaches to target selection and tractability for drug discovery, March 21, 2022
Heidi Kingdon Jones, Global Vice President of Sales & Marketing is attending the ‘Experimental and in silico approaches to target selection and tractability for drug discovery’ symposium at The Francis Crick Institute on 21st March. The meeting organised by the…
#ICAR 2022, March 21-25, 2022
IRBM’s team will be in Seattle for the 35th International Conference on Antiviral Research #ICAR 2022 March 21-25, 2022. If you are planning to be in Seattle during that time, then contact us to organize a meeting. Please do fill out…
#BioCapital Europe, March 10, 2022
IRBM’s team will be in Amsterdam for the BioCapital Europe 2022 on March the 10th. If you are planning to be in Amsterdam during that time, then contact us to organize a meeting. Please do fill out the form below and…
#Asent Virtual Meeting-American Society for Experimental Neurotherapeutics, February 28, 2022 – March 3, 2022
IRBM’s team will be attending the Asent Virtual Meeting. February 28, 2022 – March 3, 2022 If you want to get in touch with us, please do fill out the form below and we will contact you.
#17th Annual HD Therapeutics Conference CHDI Foundation, February 28, 2022-March 03, 2022
IRBM’s team will be in Palm Springs for the 17th Annual HD Therapeutics Conference February 28, 2022-March 03, 2022. If you are planning to be in Palm Springs during that time, then contact us to organize a meeting. Please do fill out…
ELRIG UK 19-20 October
Our Global Vice President of Sales & Marketing Heidi Kingdon Jones, will be attending the Drug Discovery 2021 conference hosted by ELRIG UK at the Exhibition Centre Liverpool from the 19th to the 20th of October. Drug Discovery 2021 promises to be a special event,…
Biomarkers for Neurodegenerative Diseases: Immunoassays and LC-MS/MS to Track Disease Progression
We recently had our Xtalks webinar on “Biomarkers for Neurodegenerative Diseases: Immunoassays and LC-MS/MS to Track Disease Progression” on the 12th of October, presented by our talented scientists Manuel Daldin and Pamela di Pasquale. During the webinar, Manuel and Pamela…
CamMedChem21, 13-15th September
IRBM’s Heidi Kingdon Jones will be attending Royal Society of Chemistry’s and SCI: Where Science Meets Business’s #CamMedChem21 in Cambridge on 13-15th September and is looking forward to meeting with potential new partners in person again! IRBM is an innovative contract research organization working across…
BIO-Europe Digital, 10-11 & 14-18 June
Next week IRBM’s Heidi Kingdon Jones and Michele Luche will be attending Biotechnology Innovation Organization’s #BIO2021 Digital and are looking forward to meeting with potential new partners. IRBM is an innovative contract research organization working across all aspects of #drugdiscovery and early #drugdevelopment. If you’d like to know more about…
Cambridge Healthtech Institute, Drug Discovery Chemistry Virtual, 18-20 May
We’re looking forward to attending Cambridge Healthtech Institute’s 16th Annual Drug Discovery Chemistry Virtual this week. We are delighted that IRBM will be presenting posters at the event in #infectious diseases. Jesus Maria Ontoria and Romano Di Fabio will be presenting on the #peptide discovery process of #Zika Virus protease inhibitors and #smallmolecule anti- #HBV derivatives…
17th PEGS Boston The Essential Protein Engineering and Cell Therapy Summit
We’re attending the 17th #PEGS Boston The Essential Protein Engineering and Cell Therapy Summit this week. We’re thoroughly looking forward to the various panel sessions over the next two days, especially those on #oncology and bispecific antibodies, given our expertise in these areas. At…